Skip to main content

Research Services Division

Deakin Research

Research Output for Darren Hargrave

Note: The 2012, 2013, 2014, 2015 publications have not been audited.

Jump to: Publications | Grants and Consultancies | HDR completions

Darren Hargrave may be from another institution or only recently joined Deakin University.


2015 External

Shou, Y*, Robinson, DM*, Amakye, DD*, Rose, KL*, Cho, YJ*, Ligon, KL*, Sharp, T*, Haider, AS*, Bandaru, R*, Ando, Y*, Geoerger, B*, Doz, F*, Ashley, DM, Hargrave, DR*, Casanova, M*, Tawbi, HA*, Rodon, J*, Thomas, AL*, Mita, AC*, MacDonald, TJ* and Kieran, MW* (2015) A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma, Clinical cancer research, vol. 21, no. 3, pp. 585-593, American Association for Cancer Research, Philadelphia, PA [C1]
ERA journal ID: 15915 – Scopus EID: Not tagged
DRO entry for this publication

2013 External

Hargrave, Darren*, Geoerger, Birgit*, Frappaz, Didier*, Pietsch, Torsten*, Gesner, Lyle*, Cisar, Laura*, Breazna, Aurora*, Dorman, Andrew*, Cruz-Martinez, Ofelia*, Fuster, Jose Luis*, Rialland, Xavier*, Icher, Celine*, Leblond, Pierre*, Ashley, David, Perilongo, Giorgio*, Elliott, Martin*, English, Martin*, Clausen, Niels* and Grill, Jacques* (2013) A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour study, Journal of neuro-oncology, vol. 113, no. 1, pp. 127-134, Springer, New York, N. Y. [C1]
ERA journal ID: 16444 – Scopus EID: 2-s2.0-84876895738
Citation counts: Scopus - 1, Thomson - 1
DRO entry for this publication

Vassal, Gilles*, Zwaan, C. Michel*, Ashley, David, Le, Deley Marie Cecile*, Hargrave, Darren*, Blanc, Patricia* and Adamson, Peter C.* (2013) New drugs for children and adolescents with cancer: the need for novel development pathways, Lancet oncology, vol. 14, no. 3, pp. e117-e124, Lancet Publishing Group, London, England [C1]
ERA journal ID: 16561 – Scopus EID: 2-s2.0-84875246025
Citation counts: Scopus - 2
DRO entry for this publication

2012 External

Geoerger, Birgit*, Aerts, Isabelle*, Casanova, Michela*, Chisholm, Julia C.*, Hargrave, Darren R.*, Leary, Sarah*, Ashley, David M.*, Bouffet, Eric*, Macdonald, Tobey*, Hurh, Eunju*, Dey, Jyotirmoy*, Kalambakas, Stacey*, Amakye, Dereck Dokyi* and Kieran, Mark W.* (2012) A phase I/II study of LDE225, a smoothened (Smo) antagonist, in pediatric patients with recurrent medulloblastoma (MB) or other solid tumors, in Unknown (ed.), ASCO 2012: Collaborating to conquer cancer : Proceedings of the American Society of Clinical Oncology 2012 meeting, p. 1, American Society of Clinical Oncology, Alexandria, Va. [E2.1]
DRO entry for this publication

Grants and Consultancies

No grants and/or consultancies found or audited – the 2014 HERDC financial return has not been completed or loaded as yet.

Higher Degree by Research Completions supervised by Darren Hargrave

No completions found or audited.

* Not a member of Deakin University at time of output.

DRO to publications collection last synchronised: Tuesday 2nd June 2015 10:04pm

Deakin University acknowledges the traditional land owners of present campus sites.

4th May 2015